Annals of Oncology, 0923-7534

Journal

View graph of relations

Related Publications
  1. The potential of a novel antiangiogenic VEGFR1-D2 binding peptide in oncology therapeutics

    Momtaz, A. S., Asghari, S. M. & Groves, M. R., Oct-2019, In : Annals of Oncology. 30, p. 814-815 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Paclitaxel/carboplatin/bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

    Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H. J. M., Smit, E. F., Dingemans, A-M. C., Kunert, A., Hendriks, R. & Aerts, J. G., Apr-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  3. The effect of prophylactic cranial irradiation (PCI) for young stage III NSCLC patients: Subgroup analyses of the NVALT-11/DLCRG-02 study

    Witlox, W. J. A., Ramaekers, B., Groen, H. J. M., Dingemans, A-M. C., Praag, J., Belderbos, J., Van der Noort, V., Van Tinteren, H., Joore, M. A. & De Ruysscher, D., Apr-2019, In : Annals of Oncology. 30, p. 33-34 2 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  4. EPAC-Lung: Pooled analysis of circulating tumor cells in advanced non-small cell lung cancer

    Lindsay, C. R., Blackhall, F. H., Carmel, A., Gazzaniga, P., Groen, H. J. M., Krebs, M. G., Muinelo-Romay, L., Pantel, K., Rossi, E., Terstappen, L., Wikman, H., Soria, J-C., Farace, F. F., Renehan, A., Dive, C., Besse, B. & Michiels, S., Apr-2019, In : Annals of Oncology. 30, 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  5. Circulating tumor cells are prognostic in SCLC, but still lack clinical application

    Tamminga, M. & Groen, H. J. M., Jul-2019, In : Annals of Oncology. 30, 7, p. 1031-1033 9 p.

    Research output: Contribution to journalArticleAcademic

View all (179) »

ID: 13479495